IRB Barcelona has named Joan Font-Burgada (Caldes de Montbui, Barcelona, 1977) winner of the 2018 IRB Barcelona Alumni of Excellence Award “for his important contributions to understand the development of cancer, in particular, why cancers evolve with mutations that are poorly immunogenic, and also for the identification of special hepatic reparative cells with low propensity to produce cancer,” states the report by the jury —a body formed by senior IRB Barcelona researchers with expertise across several fields of research. These findings are considered to be of great scientific and medical significance.

Joan Font-Burgada studied for his PhD in the Cell and Developmental Biology Program of IRB Barcelona between 2006 and 2010, under the supervision of Dr. Ferran Azorín. In 2010, he moved to the US to undertake a 6-year postdoctoral training period at the University of California, San Diego (Department of Pharmacology), in Dr. Michael Karin's group. As a postdoctoral fellow, he identified a new subpopulation of hepatocytes —hybrid hepatocytes— that play a pivotal role in the repair of liver damage. Using mouse models that replicate the complexity of human hepatocellular carcinoma genetics, he is working on unravelling the mechanisms of regeneration and cancer development in the liver. In 2017, he took up the position of Assistant Professor at the Fox Chase Cancer Center in Philadelphia, heading his own laboratory, which focuses on how tissue and organ degeneration, regeneration defects, and decline in regenerative capacity affect the initiation of cancer.

Font-Burgada previously received a prestigious National Cancer Institute Pathway to Independence Award ─a grant that helps highly accomplished postdoctoral researchers complete their training and transition to a faculty position. He has also been awarded a Hertzberg-Schechter Prize for Stem Cell Research.

This is the third year of the Alumni Award—a prize given in recognition of outstanding contributions to science and the scientific community by young researchers who completed a significant part of their training and careers at IRB Barcelona. Supported by Eppendorf, the prize consists of a commemorative certificate, an award of 2,000 €, and an expenses-paid trip to IRB Barcelona in 2018 to give a talk in the Barcelona Biomed Seminar Series.

David Vilchez, Group Leader at the CECAD-Cluster of Excellence in Cologne (Germany), received the award in 2016, and Marc Liesa, Assistant Professor in-residence in the Department of Medicine at the University of California, Los Angeles (UCLA) David Geffen School of Medicine, was the winner in 2017.

With the support of Eppendorf.

Image: Joan Font-Burgada, 2018 IRB Barcelona Alumni of Excellence Awardee.

Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream